Competent team with innovative ideas
FIBROTX is a privately held company founded in November 2005. Our company is providing innovative tools for personalized dermatology and skin care. FibroTx is housed in state-of-the-art laboratory and prototype-manufacturing facilities at the Tallinn Science Park Tehnopol, Estonia.
OUR RESEARCH TEAM consists of highly competent and qualified professionals. We have extensive experience in biomarker research and assay development.
OUR MISSION is to develop, manufacture and market non-invasive skin diagnostic devices based on proprietary technologies (patents pending):
- FibroTx TAP (Transdermal Analysis Patch): A highly versatile research and development tool for multiplex analyses of protein-based biomarkers on skin. TAP is being offered to customers as a fee-for-service skin diagnostic tool.
- FibroTx Patch: A non-invasive highly versatile easy-to-use test that allows qualitative and quantitative analysis of biomarkers directly from skin surface. FibroTx Patch allows measuring up to 15 different biomarkers with a single test.
- FibroTx SELF (Skin Exploratory Lateral Flow): A skin diagnostic device for multiplex analyses of biomarkers from skin for specialists and home use.
OUR PARTNERS and collaborators in Estonia include Tartu University Hospital, East-Tallinn Central Hospital, North Estonia Medical Centre. Our international partners include Radboud University Medical Centre (Radboudumc) in Netherlands; Centre for Human Drug Research (CHDR) in Netherlands, Bioskin in Germany and many others.
„Development of transdermal analysis patch for cosmetic and dermatology use“ was co-financed by the European Regional Development Fund and was implemented during the period 01.07.2011 to 30.06.2014.
FibroTx is an ISO 9001 certified company since 2008.